A Pilot Follow-up Study of Investigating the Effect of Pramipexole on Metabolic Network Activity Compared With Levodopa in Chinese Patients With Early Parkinson's Disease.
Phase of Trial: Phase II
Latest Information Update: 08 Mar 2016
At a glance
- Drugs Levodopa/carbidopa (Primary) ; Pramipexole (Primary)
- Indications Parkinson's disease
- Focus Biomarker; Therapeutic Use
- 25 Aug 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 26 Aug 2013 Planned end date changed from 1 Aug 2014 to 1 Feb 2015 as reported by ClinicalTrials.gov.
- 26 Aug 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.